{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:40:43Z","timestamp":1790642443097,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Medicines Initiative Joint Undertaking","award":["115156"],"award-info":[{"award-number":["115156"]}]},{"name":"European Union's Seventh Framework Programme","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}]},{"name":"Academic and SME partners"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ijantimicag.2017.10.019","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T04:23:52Z","timestamp":1510115032000},"page":"399-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predicting mutant selection in competition experiments with ciprofloxacin-exposed Escherichia coli"],"prefix":"10.1016","volume":"51","author":[{"given":"David D.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernilla","family":"Lagerb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Malmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders N.","family":"Kristoffersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Wistrand-Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cao","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Cars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan I.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diarmaid","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet I.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena E.","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0010","author":"The PEW Charitable Trusts"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0015","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/CMR.00033-13","article-title":"Investigational antimicrobial agents of 2013","volume":"26","author":"Pucci","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/microbe.9.147.1","article-title":"Cautious optimism for the antibacterial pipeline","volume":"9","author":"Pucci","year":"2014","journal-title":"Microbe Mag"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2017.10.019_bib0025","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/514916","article-title":"Antibiotic-selective environments","volume":"27","author":"Baquero","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0030","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1124\/pr.111.005769","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling of antibacterial drugs","volume":"65","author":"Nielsen","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0035","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1128\/AAC.00182-11","article-title":"Pharmacokinetic\/pharmacodynamic (PK\/PD) indices of antibiotics predicted by a semimechanistic PK\/PD model: a step toward model-based dose optimization","volume":"55","author":"Nielsen","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0040","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jac\/dkw057","article-title":"A pharmacokinetic\u2013pharmacodynamic (PK\/PD) model based on in vitro time\u2013kill data predicts the in vivo PK\/PD index of colistin","volume":"71","author":"Khan","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0045","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1016\/j.bmc.2016.08.034","article-title":"From lead optimization to NDA approval for a new antimicrobial: use of pre-clinical effect models and pharmacokinetic\/pharmacodynamic mathematical modeling","volume":"24","author":"Drusano","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1517\/17425255.2016.1123250","article-title":"Pharmacokinetics and pharmacodynamics in antibiotic dose optimization","volume":"12","author":"Sy","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0055","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.drudis.2007.10.002","article-title":"The role of mechanism-based pharmacokinetic\u2013pharmacodynamic (PK-PD) modelling in translational research of biologics","volume":"12","author":"Agoram","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0060","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tips.2008.01.007","article-title":"Mechanism-based pharmacokinetic\u2013pharmacodynamic (PK-PD) modeling in translational drug research","volume":"29","author":"Danhof","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0065","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.00604-06","article-title":"Semimechanistic pharmacokinetic\/pharmacodynamic model for assessment of activity of antibacterial agents from time\u2013kill curve experiments","volume":"51","author":"Nielsen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0070","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/jac\/dkv233","article-title":"A mechanism-based pharmacokinetic\/pharmacodynamic model allows prediction of antibiotic killing from MIC values for WT and mutants","volume":"70","author":"Khan","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0075","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/jac\/dkt520","article-title":"A pharmacokinetic\/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing","volume":"69","author":"Mohamed","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0080","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1093\/jac\/dkx269","article-title":"Can a pharmacokinetic\/pharmacodynamic (PKPD) model be predictive across bacterial densities and strains? External evaluation of a PKPD model describing longitudinal in vitro data","volume":"72","author":"Nielsen","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002158","article-title":"Selection of resistant bacteria at very low antibiotic concentrations","volume":"7","author":"Gullberg","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000541","article-title":"Interplay in the selection of fluoroquinolone resistance and bacterial fitness","volume":"5","author":"Marcusson","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0095","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1128\/AAC.40.11.2478","article-title":"Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model","volume":"40","author":"L\u00f6wdin","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0100","series-title":"Optimum experimental designs","author":"Atkinson","year":"1992"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0105","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cmpb.2012.05.005","article-title":"PopED: an extended, parallelized, nonlinear mixed effects models optimal design tool","volume":"108","author":"Nyberg","year":"2012","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0110","series-title":"NONMEM user's guides (1989\u20132009)","author":"Beal","year":"2009"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","article-title":"PsN-Toolkit\u2014a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM","volume":"79","author":"Lindbom","year":"2005","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.ijantimicag.2017.10.019_bib0120","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1128\/AAC.01286-10","article-title":"Predicting in vitro antibacterial efficacy across experimental designs with a semimechanistic pharmacokinetic\u2013pharmacodynamic model","volume":"55","author":"Nielsen","year":"2011","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917303928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917303928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T13:40:11Z","timestamp":1589809211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917303928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0924857917303928"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.10.019","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting mutant selection in competition experiments with ciprofloxacin-exposed Escherichia coli","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}